• Future Disparities Between Demand And Supply of Tertiary Emergency Care In Regions Affected By The Great East Japan Earthquake

    Nov 1, 2016, 00:00

  • Arbitration Board Setting Reimbursement Amounts For Pharmaceutical Innovations In Germany When Price Negations Between Payors And Manufacturers Fail- An Empirical Analysis Of 5 Years' Experience

    Nov 1, 2016, 00:00

  • Presence of Lipohypertrophy and its Relation to Insulin Injection Practices in Patients with Type 1 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Participation Of External Medical Societies In The Benefit Assessment Of Pharmaceuticals In Germany

    Nov 1, 2016, 00:00

  • Cost–Effectiveness of Different Strategies for Prevention of Venous Thromboembolism after Total Hip Replacement in China

    Nov 1, 2016, 00:00

  • Construction of System Dynamics Model for Medical Care System of Japan

    Nov 1, 2016, 00:00

  • The Economic Burden of Hepatitis C In France And Romania

    Nov 1, 2016, 00:00

  • The Association with Psychiatric Diseases and Patients with Chronic Spontaneous Urticaria in Taiwan

    Nov 1, 2016, 00:00

  • Comparison Between Eq-5d And Hui In Japanese Population Norms

    Nov 1, 2016, 00:00

  • Patient Information And Consent Form In Europe- Requirements From Regulatory Authorities For Pharmaco-Epidemiological Studies

    Nov 1, 2016, 00:00

  • Validity of Child Health-6 Dimension(CH-6D) for Adolescents

    Nov 1, 2016, 00:00

  • Assessing the Gap Between Prioritized Conditions and Covered Conditions in Current Legislation for Rare and Orphan Diseases in Peru

    Nov 1, 2016, 00:00

  • Budget Impact Associated With The Implementation Of A Dtpa-Ipv-Hepb/Hib Hexa Vaccination Program In Slovenia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Recombinant Human Follicle Stimulating Hormone Biosimilars In Portugal

    Nov 1, 2016, 00:00

  • Estimated Costs of Locoregional and Metastatic Recurrences in Patients with HER2+ Breast Cancer in Spain

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Using Brentuximab Vedotin in Patients with Recurrent Hodgkin Lymphoma or Refractory to Transplant

    Nov 1, 2016, 00:00

  • A Comparison of Insulin Degludec Clinical Evaluations and Recommendations Between an Independent HTA and National HTA Bodies

    Nov 1, 2016, 00:00

  • The Choice of A Fluoropyrimidine Regimen in Patients with Advanced Colorectal Cancer

    Nov 1, 2016, 00:00

  • Clinical And Economic Impact of Treatment-Free Interval In Patients With Relapsed/Refractory Multiple Myeloma

    Nov 1, 2016, 00:00

  • A Propensity Score Matched Study of Plasmablade Vs Coblation Technology During Pediatric Tonsillectomy and Adenoidectomy Procedures

    Nov 1, 2016, 00:00

  • Effects of A Chronic Obstructive Pulmonary Disease Integrated Care Pathway Programme in Singapore

    Nov 1, 2016, 00:00

  • How Does the Additional Benefit Extend of Orphan Drugs Impact Price Negotiations in the German Outpatient Sector?

    Nov 1, 2016, 00:00

  • Pay For Performan A Proposal For And Simulation Of Real Time Outcomes-Based Pharmaceutical Pricing Using Routinely Collected Data

    Nov 1, 2016, 00:00

  • The Impact of Extrapolating Survival Based on Cure Models- Comparing Mean Incremental Survival and Cure Rates in Different Datasets

    Nov 1, 2016, 00:00

  • Assessment of Health Related Quality of Life (Hrqol) of Patients with Severe Mental Illness Attending Tertiary Care Public Hospitals of Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Insulin Degludec Treatment in Patients with Type1 and Type 2 Diabetes Mellitus- A Systematic Review

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Ketoconazole Versus Metyrapone for the Treatment of Cushing’s Syndrome in a Swedish Setting

    Nov 1, 2016, 00:00

  • Is There A Difference In Perception And Practice In Pharmacological Management Of Schizophrenia- A Cross Sectional Survey In India

    Nov 1, 2016, 00:00

  • Predictors of Disease Progression in Mild Alzheimer’s Disease Dementia Patients – Results From the Geras Real World Cohort and Expedition Trials

    Nov 1, 2016, 00:00

  • The Economic Burden of Heart Failure in Latin America

    Nov 1, 2016, 00:00

  • Impact of Initiation of Long-Acting Injectable Antipsychotics on Resource Utilization In Patients with Schizophrenia

    Nov 1, 2016, 00:00

  • Spiralling Healthcare Expenditure in Malaysia- Is it Sustainable?

    Nov 1, 2016, 00:00

  • Creating Useful and Comprehensive Decision Support Tools for Selecting and Designing Managed Entry Agreements

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Sucroferric Oxyhydroxide in Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease

    Nov 1, 2016, 00:00

  • Trends in Health Technology Assessments since the Introduction of Cost-Effectiveness in the Netherlands

    Nov 1, 2016, 00:00

  • A Prospective Study of Antihypertensive Drugs Utilization Pattern in Outpatients of a Tertiary Care Teaching Hospital

    Nov 1, 2016, 00:00

  • Identifying Patient Reported Signs and Symptoms of Being Overweight and Obese

    Nov 1, 2016, 00:00

  • Severe Sepsis In Adults- Impact of Diagnostic Coding on Hospital Resource Utilization

    Nov 1, 2016, 00:00

  • Prediction of the Morbidity with Bacterial Purulent Meningitis of Various Origin with Consideration of the Existing Vaccine Prevention Procedures

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of National Cervical Cancer Screening Program in Denmark- Cytology with HPV triage vs. HPV Primary Screening with Reflex Cytology Triage Cintec Plus Cytology

    Nov 1, 2016, 00:00

  • Variation in the Number and Type of Heart Valve Procedures Performed in the UK – Is Patient Access Equitable?

    Nov 1, 2016, 00:00

  • Iatrogenic Hypoglycaemia in the Elderly- An Analysis of Diabetic Medication Usage Patterns According to Age

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Guanfacine Extended-Release Treatment in Pediatric Attention-Deficit/Hyperactivity Disorder

    Nov 1, 2016, 00:00

  • assessment Of Willingness To Pay For Consultaion And Diagnostic Services In Sheikh Khalifa Bin Zayyed Al-Nayyan Medical Complex, Quetta

    Nov 1, 2016, 00:00

  • ND1 Burden And Work Productivity Loss Impairment From Providing Care To Alzheimer's Disease Patients

    Nov 1, 2016, 00:00

  • Increased Use of Effective Non-Cancer Drugs Following Removal of Benefit Caps Among Cancer Patients In Medicaid- A Quasi-Experimental Study

    Nov 1, 2016, 00:00

  • Increased Clinical and Economic Benefit in Spain Associated with Improvement to ±8.5% of The Accuracy of Glucose Meters Adapted to The Current ISO 15197-2013 (±15%)

    Nov 1, 2016, 00:00

  • Analysis of Affordability and Consumption of Statins in Ukraine in 2015

    Nov 1, 2016, 00:00

  • How To Ensure An Efficient Resource Allocation For The Treatment of Chronic Myeloid Leukemia

    Nov 1, 2016, 00:00

  • ‘Severe Illness Insurance' in China- Impact of the New Coverage on Access to Health Care and Innovative Drugs

    Nov 1, 2016, 00:00

  • A Qualitative Study to Explore The Experiences of Lung Cancer Patients About Disease and its Prevention

    Nov 1, 2016, 00:00

  • A Systematic Review Of The Cost-Effectiveness Of Quadrivalent Influenza Vaccine

    Nov 1, 2016, 00:00

  • Impact Of Changes In The Methodology Of External Price Referencing On Prices

    Nov 1, 2016, 00:00

  • Economic Evaluation of Diacerein, Diclofenac and Glucosamine for Osteoarthritis in China

    Nov 1, 2016, 00:00

  • Using Best-Worst Scaling Choice Experiments to Elicit the Most Important Domains of Health-Related Quality of Life (HRQOL) in Singapore

    Nov 1, 2016, 00:00

  • Psychometric Properties Of The Finnish Version Of The Locomotor Capabilities Index-5

    Nov 1, 2016, 00:00

  • Evaluating Patient Access to Targeted Therapeutics Amidst the Evolving Singaporean Health Care Landscape

    Nov 1, 2016, 00:00

  • A Time Series Analysis of Social Insurance and Patient Costs of Reimbursed Medical AIDS in Hungary

    Nov 1, 2016, 00:00

  • A Review of the Cost of Medication Nonadherence in Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Epidemiological Profiling of Chronic Headache Patients At A Public Tertiary Care Setting in India

    Nov 1, 2016, 00:00

  • Treatment Outcomes Following Initiation of Dapagliflozin or Basal Supported Oral Therapy Among Type 2 Diabetes Patients In Primary Care Practices In Germany

    Nov 1, 2016, 00:00

  • How is Radiotherapy Reimbursed Across Europe? Results of The Health Economics in Radiation Oncology’s Survey

    Nov 1, 2016, 00:00

  • Effect of Smoking Status on Costs-of-Illness in Patients with a Depressive Disorder in Spain- An Approximation from the National Health Survey

    Nov 1, 2016, 00:00

  • Clinical And Economic Outcomes Of Patients Hospitalized For Herpes Zoster In Hong Kong

    Nov 1, 2016, 00:00

  • Efficacy and Safety Profile of Lenvatinib and Sorafenib in The Treatment of Adult Patients with Advanced Radioactive-Iodine-Refractory Differentiated Thyroid Cancer (RR-DTC)

    Nov 1, 2016, 00:00

  • Health Technology Assessment of the use Vaccines for Prevention Flu

    Nov 1, 2016, 00:00

  • Comparison of Mirena Intrauterine Device with Oral Progesterone Treatment and Surgical Treatment in Idiopathic Menorrhagia Patients- Results of A Cost-Minimisation Analysis

    Nov 1, 2016, 00:00

  • Improving Medication Adherence Through Calendar Packaging- Results of A Randomized Controlled Trial among Hypertensive Patients in Malaysia

    Nov 1, 2016, 00:00

  • A Review Of Patient-Reported Outcome Measures To Assess Infertility-Related Quality Of Life

    Nov 1, 2016, 00:00

  • Consolidation of China's Two Basic Medical Insurance Programs- Understanding New Opportunities for Access

    Nov 1, 2016, 00:00

  • To What Extent Does the Published Economic Analyses of Treatments for Opioid Use Disorder Capture its Chronic, Relapsing Nature and its Impact on Society?

    Nov 1, 2016, 00:00

  • Evaluating The Economic Impact Of Potentially Inappropriate Prescribing In Older People In Ireland Using A Markov Modelling Approach

    Nov 1, 2016, 00:00

  • Teledermoscopy as a Referral Method in Australia- A Decision Analytic Model

    Nov 1, 2016, 00:00

  • Health State Utilities for Persistent, Recurrent or Metastatic Cervical Cancer in France

    Nov 1, 2016, 00:00

  • Understanding Continuity of Care at a Provider and Practice Level

    Nov 1, 2016, 00:00

  • Heart Rate Recovery in Inflammatory Bowel Disease (Ibd)

    Nov 1, 2016, 00:00

  • Societal Impact of One-Time Screening for Diabetes at Age 30 in the Indian Population- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Budget Impact Of Ulipristal Acetate 5mg In Pre-Operative Treatment Of Uterine Fibroids- An Analysis Based On Public Data On Hospital Stays In France

    Nov 1, 2016, 00:00

  • Outcomes Prediction Using a Generalized Linear Model in a Cohort of Schizophrenic Patients Receiving Paliperidone Long Acting Injectable Treatment in Hong Kong

    Nov 1, 2016, 00:00

  • Health Technology Assessment (HTA) for Orphan Drugs in Cost-Effectiveness (CE) Markets- Current Development and Future Trends

    Nov 1, 2016, 00:00

  • Data Imputation for Missing Values in a Claim-Based Administrative Database- Comparison of Imputatation Approaches

    Nov 1, 2016, 00:00

  • Impact of The International Reference Pricing on Access To Standard Therapy Drugs for Asthma and Copd

    Nov 1, 2016, 00:00

  • Burden of Cancers Attributable to Tobacco Smoking in Member Countries of the Association of South East Asian Nations (Asean), 2012

    Nov 1, 2016, 00:00

  • Study On Medication Adherence Behavior And Quality Of Life In Elderly Diabetc, Hypertension Patients In A Tertiary Care Hospital; A Prospective Study

    Nov 1, 2016, 00:00

  • Assessment of Secondary Recurrence of Stroke in Aspirin-Clopidogrel Combination Therapy and Aspirin Monotherapy in Transient Ischemic Attack Patients in South India- A Comparative Study

    Nov 1, 2016, 00:00

  • HBSAG Seroclearance after Treatment-Induced HBEAG Seroclearance in Chronic Hepatitis B Patients in Beijing, China

    Nov 1, 2016, 00:00

  • Pediatric Registry Of Patients With Severe Persistent Uncontrolled Asthma Receiving Omalizumab

    Nov 1, 2016, 00:00

  • The Comparative Pharmacoeconomic Analysis of Using Different Reperfusion Strategies for Patients with St Segment Elevation Myocardial Infarction (STEMI)

    Nov 1, 2016, 00:00

  • The Impact of Different Gastrointestinal Symptoms on The Well-Being of Affected Patients - Utility Weights for The Gastrointestinal Symptom Score (GIS)

    Nov 1, 2016, 00:00

  • Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices in Germany

    Nov 1, 2016, 00:00

  • Type 2 Diabetes in Turkey – A Cost of Illness Study

    Nov 1, 2016, 00:00

  • DRG Appropriateness Analysis Using Activity-Based-Costing Method – A Case of Burn Diagnosis

    Nov 1, 2016, 00:00

  • Cost Analysis of Human Genome Sequencing in Cancer Diagnosis in Fran Next Generation Sequencing

    Nov 1, 2016, 00:00

  • Translation And Validation Of Condition-Specific Quality Of Life Pfdi-20 And Pfiq-7 Questionnaires For Women With Pelvic Floor Dysfunction In The Norwegian Context

    Nov 1, 2016, 00:00

  • Pharmacotherapies for the Treatment of Behavioral and Psychological Symptoms of Dementia - A Systematic Review On Recent Evidence

    Nov 1, 2016, 00:00

  • Risk of Motor-Vehicle Accidents Increases with Multimorbidity

    Nov 1, 2016, 00:00

  • Impact Of Post-Inscription Studies On Reassessment In Fran A Case Study On Orphan Drugs

    Nov 1, 2016, 00:00

  • Virtual Planning and Patient-Specific Implants in Mandibular Reconstructionsurgery- A Micro-Costing Analysiss

    Nov 1, 2016, 00:00

  • Applying A Simulation Model to Manage Waiting Lists For Hospital Inpatient Activity in AN EU Region

    Nov 1, 2016, 00:00

  • The Impacts of Case Payment in Rural Hainan of China

    Nov 1, 2016, 00:00

  • Developing a Geospatial Web and Mobile Application to Improve Expanded Program on Immunization in Ghana- A Mhealth Technology Novelty, 2015

    Nov 1, 2016, 00:00

  • Preliminary Cost-Effectiveness Assessment of 3D Printed Anatomic Models for Congenital Heart Diseases

    Nov 1, 2016, 00:00

  • Network Meta-Analysis Across Longitudinal Time Points- A Comparison of Available Methods

    Nov 1, 2016, 00:00

  • Adoption of Innovative Technologies and Substitution Effects- Computed Tomographic Coronary Angiography In Australia

    Nov 1, 2016, 00:00

  • The Follow-Up and Utilization of Drug Treatment for Chronic Hbv/Hcv Patients with Major Psychiatric Diseases in Taiwan

    Nov 1, 2016, 00:00

  • The 2012 Updated Beers Criteria in Falls Related Hospitalization in Older Adults

    Nov 1, 2016, 00:00

  • Oral And General Health Related Quality of Life In Times of Crisis In Greece

    Nov 1, 2016, 00:00

  • Efficacy of The Fixed Combination of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Vs Traditional Topical Treatment In Psoriasis- A Bayesian Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Cost Of Total Parenteral Nutrition Services At Ministery Of Health In Saudi Arabia

    Nov 1, 2016, 00:00

  • Measures Taken By The Romanian Ministry Of Health For Better Access To Anti-Egfr Drugs

    Nov 1, 2016, 00:00

  • ORphan Drug Market Analysis In Turkey

    Nov 1, 2016, 00:00

  • Analysis Of Real Data For Treatment Of Nausea And Vomiting Of Pregnancy (Nvp) In Ukraine

    Nov 1, 2016, 00:00

  • Comparative Exploratory Analysis on Effectiveness, Tolerability And Patient/Nurse Satisfaction With Two Non-Invasive Patient Controlled Analgesia Treatments For Acute Post-Operative Pain Management

    Nov 1, 2016, 00:00

  • Patient Reported Outcomes - Patient Satisfaction With Selected Characteristics of Rehabilitation Medical Devices - Usage, Acquisition, offer, Range And Quality

    Nov 1, 2016, 00:00

  • The Economic Burden of Atrial Fibrillation in Latin America

    Nov 1, 2016, 00:00

  • Real-World Quality-Adjusted Life-Years Gains In Portuguese Patients with Rheumatoid Arthritis Following 1 Year of Golimumab Treatment

    Nov 1, 2016, 00:00

  • Hospital Resource Utlization of Patients Over 40 Years old with Chronic Obstructive Pulmonary Disease in South Korea

    Nov 1, 2016, 00:00

  • The Normal Reimbursement Procedure Of The Pharmaceutical Submissions Between 2013 And 2015 In Hungary - Needs And Results

    Nov 1, 2016, 00:00

  • Value Added Medicines- What Value Repurposed Medicines Might Bring To Society?

    Nov 1, 2016, 00:00

  • Health Outcomes Assessment and Treatment Regimens For Patients with Gastric Cancer in Shanghai China

    Nov 1, 2016, 00:00

  • Choosing First-Line Treatment of Metastatic Colorectal Cancer Based on Biomarker Ras Status- A Budget Impact Analysis From Brazilian Health Insurance System Perspective

    Nov 1, 2016, 00:00

  • The mothif study. Costs of Clotting Factors In Haemophilia A And B- A Review From The Berhlingo Database In Seven Comprehensive Health Care Centres In France

    Nov 1, 2016, 00:00

  • Effectiveness Of Self-Monitoring Of Blood Glucose (Smbg) In Reducing Hba1c Of Diabetes Mellitus Type-2 Patients In Jakarta, Indonesia- Preliminary Findings

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Serum Free Light Chain Assay (FREELITE®) for The Diagnosis of Monoclonal Gammopathy in The Brazilian Public and Private Healthcare Systems

    Nov 1, 2016, 00:00

  • Cost Study of Respiratory System Diseases

    Nov 1, 2016, 00:00

  • Aligned and Flexible? A Comparative Review of SMC and Nice Decision-Making

    Nov 1, 2016, 00:00

  • Burden of Medically Attended Acute Gastroenteritis in England- A Cohort Study in CPRD

    Nov 1, 2016, 00:00

  • Patient Group Submissions (PGSS) in Health Technology Assessment (HTA) In Scotland- Prevalence And Impact

    Nov 1, 2016, 00:00

  • The value of timely implementation in hiv/sti testing- cost-effectiveness vs. Speed of intervention rollout

    Nov 1, 2016, 00:00

  • Viability Of Using Electronic Medical Records From European Countries As Data In Novelty (A Novel Observational Longitudinal Study Of Patients With Asthma And/Or Copd)

    Nov 1, 2016, 00:00

  • Real-World Treatment Patterns and Outcomes for Patients with Advanced Soft Tissue Sarcoma Receiving Systemic Therapy in The United Kingdom

    Nov 1, 2016, 00:00

  • Analysis of the Costs Associated with the Management of Adverse Events Compared Through Tkis in the Treatment of Patients with Non-Small Cells Lung Cancer EGFR Mutated

    Nov 1, 2016, 00:00

  • Innovative Therapies for The Treatment of Cancer- An Overview of Late-Phase Clinical Development

    Nov 1, 2016, 00:00

  • How to Handle Data Quality Issues in EQ-5D-5L Valuation Studies. The Spanish Case

    Nov 1, 2016, 00:00

  • Indicators in Evaluating Financial and Economic Performance of Pharmacy- A Systematic Review

    Nov 1, 2016, 00:00

  • Systematic Review of Health State Utilities in Children with Asthma

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of the Pharmacist-Assisted Warfarin Monitoring Program (PAWM) at a Medical Center in Taiwan

    Nov 1, 2016, 00:00

  • Impact of Glucosamine on the Burden of Knee Osteoarthritis Over A 6 Month-Period in Fran An Observational Study

    Nov 1, 2016, 00:00

  • The Importance of Model Conceptualisation- A Case Study in Ankylosing Spondylitis (AS) and Non-Radiographic Axial Spondyloarthritis (NR-AXSPA)

    Nov 1, 2016, 00:00

  • Translation of the UK Paediatric Influenza Primary School Vaccination Programme to 13 European Countries Using a Dynamic Transmission Model

    Nov 1, 2016, 00:00

  • Impact of National Criteria and Healthcare System Characteristics on Access to Biologic Dmards in Rheumatoid Arthritis In Europe

    Nov 1, 2016, 00:00

  • Current Trends in Methods of Pharmacoeconomic Studies of Cancer Therapies in China

    Nov 1, 2016, 00:00

  • Comparing The Safety Profiles Of Biosimilars With Their Originators’- A Cross Sectional Analysis On The Eu-Rmp

    Nov 1, 2016, 00:00

  • Cost-Utility of Unicompartmental Compared To Total Knee Replacements- An Analysis Based on Matched Routinely-Collected Data From The United Kingdom

    Nov 1, 2016, 00:00

  • Differentiation Of Health Related Quality Of Life Outcomes Between Patient Populations; Results From Patients With Breast Cancer, Rheumatoid Arthritis, Multiple Sclerosis, Rare Cancers And Rare Diseases

    Nov 1, 2016, 00:00

  • Change Management of Polypharmacy and Adheren The Experience of Eu Simpathy Program

    Nov 1, 2016, 00:00

  • Real World Data in Health Technology Assessments –Use of Routinely Collected Data to Address Epidemiologic Questions in Kidney Transplantation in the Amnog Process in Germany

    Nov 1, 2016, 00:00

  • The Dynamic Evolution of External Price Referencing Implementation in Various Countries

    Nov 1, 2016, 00:00

  • The Economic Burden of Schizophrenia in Malaysia

    Nov 1, 2016, 00:00

  • Efficiency in Use of Lensx Vs Phacoemulsification Surgery for Cataract Treatment- Results from a Global Observational Study

    Nov 1, 2016, 00:00

  • Association of Patient-Reported Anxiety and Depression with Clinical Measurements, Disability, and Treatment Satisfaction Among Patients with Rheumatoid Arthritis

    Nov 1, 2016, 00:00

  • Effect of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Statins on Sepsis-Related Outcomes

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life in Opioid use Disorder Measured by Utilities- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Reconsidering Drugs Funded Via The Cancer Drugs Fund in England- What’s New This Time?

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam

    Nov 1, 2016, 00:00

  • A Cost-Utility Analysis of Dabigatran, Enoxaparin, and Usual Care for Venous Thromboprophylaxis after Hip or Knee Replacement Surgery in Thailand

    Nov 1, 2016, 00:00

  • Systematic Literature Review and Assessment of the Reporting Quality of Economic Evaluation Studies in Non-Small Cell Lung Cancer in China

    Nov 1, 2016, 00:00

  • A Trial-Based Euroqol Eq-5d Health Utility Analysis in Patients with Previously Treated Advanced Nsclc

    Nov 1, 2016, 00:00

  • Economic Evaluation Of Abbvie’s Regimen (Viekirax/Exviera) For Patients With Genotype 1a Hcv In Greece

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Everolimus for Patients with Advanced Neuroendocrine Tumors of the Gastrointestinal (GI) or Lung Origin -A Canadian Societal Health Care System Perspective

    Nov 1, 2016, 00:00

  • Barriers Influencing Implementation of Guidelines Into Clinical Practice in Czech Republic

    Nov 1, 2016, 00:00

  • The Impact of Cancer Prevention and Treatment Policy on Increasing Incidence of Early-Stage Cancer in Taiwan

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Aspects of Different Inhibitors of Tyrosine Kinase in First-Line Therapy of Patients with Advanced Non-Small Cell Lung Cancer with A Mutation in Epidermal Growth Factor Receptor (EGFR) Gene

    Nov 1, 2016, 00:00

  • How Does Pricing and Access of Innovative Oncology Agents in China Compare with Other Asian Markets?

    Nov 1, 2016, 00:00

  • Factors Affecting Prolonged Length of Stay In Patents With Mood Disorders

    Nov 1, 2016, 00:00

  • Quality of Life (QOL) and Health Utility (UT) in Patients with Type 2 Diabetes Mellitus (DM2) Receiving Different Oral Hypoglycemic Therapy in a Real-World Setting

    Nov 1, 2016, 00:00

  • What is an Efficient and Affordable Trastuzumab Therapy in a Middle-Income Country? - Adjuvant Therapy with Trastuzumab in Management of Early HER2-Positive Breast Cancer in Iran

    Nov 1, 2016, 00:00

  • Fabrication of Anti-Vitiligo Ointment Containing Psoralia Corylifolia- Invitro and Invivo Characterization

    Nov 1, 2016, 00:00

  • Diffusion of Trans-Arterial Radioembolization for The Treatment of Intermediate-Advanced Hepatocellular Carcinoma in Italy- A Budget Impact Analysis

    Nov 1, 2016, 00:00

  • Analysing The Evolution of Cancer Drug Prices in France Since 2000

    Nov 1, 2016, 00:00

  • Identifying The Unmet Medical Need of Angelman Syndrome- Results of A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Bariatric Surgery Compared With Non-Surgical Treatment of Morbid Obesity In Poland

    Nov 1, 2016, 00:00

  • Impact of Adoption of A New Drug on the Trends in Utilization Patterns Changes and Pharmaceutical Expenditure- An Example of Urate-Lowering Therapy

    Nov 1, 2016, 00:00

  • Estimating The Impact Associated To The Use Omalizumab In The Treatment of Severe Persistent Allergic Asthma In Portugal – Evaluating Outcomes And Treatment Costs Using Real World Data From Portuguese Patients

    Nov 1, 2016, 00:00

  • Review of Clinical Practice Guidelines and Treatment Patterns in Metastatic Pancreatic Cancer in EU-5 Countries

    Nov 1, 2016, 00:00

  • Drug Utilization Evaluation of Antibiotics in General Medicine Department of a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • The Pareto Principle ("80−20 Rule") In Healthcare Services In Greece

    Nov 1, 2016, 00:00

  • Costs of HPV-Related Cancers in The Netherlands

    Nov 1, 2016, 00:00

  • Economic Burden of Gefitinib Versus Pemetrexed for Insured Patients with Lung Cancer in Urban Xinjiang Province, China- A Real World Research

    Nov 1, 2016, 00:00

  • A Systematic Review- Economic Burden Of Needlestick Injuries On Healthcare Workers

    Nov 1, 2016, 00:00

  • The Cost Of Multiple Sclerosis In 16 European Countries- Functional Status, Symptoms And Mental Factors Drive Costs

    Nov 1, 2016, 00:00

  • Measuring The Influence Of Patient Counseling At Tertiary Care Hospital In Antenatal Care, South Karnataka, India

    Nov 1, 2016, 00:00

  • Treatment of Upper-Extremity Sarcoma with Limb-Salvage Procedures Showed Good Functional Outcomes- A Pilot Study Of 13 Consecutive Patients

    Nov 1, 2016, 00:00

  • Benefits of An Automatic Tool For Glucose Pattern Detection

    Nov 1, 2016, 00:00

  • Self-Reported Sleep Quality, Duration And Health-Related Quality Of Life In Older Chinese

    Nov 1, 2016, 00:00

  • Association between Copayment, Medication Adherence and Outcomes in the Management of Patients with Diabetes and Heart Failure

    Nov 1, 2016, 00:00

  • Use of Health Economic Information in the Management of Health Care Resource Allocation

    Nov 1, 2016, 00:00

  • Weakness of Registration Bioequivalent Drugs

    Nov 1, 2016, 00:00

  • The Impact of Atrial Fibrillation on the Economic Burden of Ischemic Stroke Patients in Beijing

    Nov 1, 2016, 00:00

  • Mapping The Policy Response To Breast Cancer In Asia

    Nov 1, 2016, 00:00

  • Analysis of Two Pressure Ulcer Dressings for Cost Reduction In The Brazilian Public Health System

    Nov 1, 2016, 00:00

  • Comparing Coronary Artery Disease Treatment Outcomes – An Example Based on Health-Related Quality of Life Measurements

    Nov 1, 2016, 00:00

  • A Simulation Model for Peripheral Arterial Disease- Methods and Application of A Markov Model

    Nov 1, 2016, 00:00

  • Extended Half-Life Coagulation Factor IX In Haemophilia B Prophylaxis- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Artificial Integligence To Support The Development Of Health Technology Assessment Reports

    Nov 1, 2016, 00:00

  • Combination Oncologics- A Boon or Burden to Healthcare Systems?

    Nov 1, 2016, 00:00

  • The Utilization Of Selected Screening Tests In Gree A Descriptive Analysis

    Nov 1, 2016, 00:00

  • A Systematic Review and Network Meta-Analysis of Intravitreal Aflibercept Injection Versus other Treatments For Macular Edema Secondary to Central Retinal Vein Occlusion

    Nov 1, 2016, 00:00

  • Local Utilities for Local Studies- Data Availability and Methodology in Japan and Korea

    Nov 1, 2016, 00:00

  • Financial Analysis of the Final Prices, Co-Paymants and Reimbursment of Antihypertensives in Slovakia from 2008-2014

    Nov 1, 2016, 00:00

  • Health Insurance Cost of Stroke in Hungary- A Cost of Illness Study

    Nov 1, 2016, 00:00

  • Cost-Benefit Analysis of Dental Prosthesis in Ukraine

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis of Alternative Treatment Options for Colorectal Cancer in Greece

    Nov 1, 2016, 00:00

  • The Study of the Effect of Pharmacy Manager's Managerial Skills on the Performance of Community Pharmacies of Tehran

    Nov 1, 2016, 00:00

  • A Qualitative Comparison of German and UK Health Technology Assessments- Vedolizumab Case Study

    Nov 1, 2016, 00:00

  • Eltrombopag Vs Romiplostim In Adult Patients With Chronic Immune Trombocytopenia- Economic Evaluation

    Nov 1, 2016, 00:00

  • Changing Of Prescriptions For Diabetes, Hyperlipidemia, And Hypertension, From Generic Drugs To Protected Brand Drugs - A Retrospective Cohort Study Using A National Inpatient Database In Japan

    Nov 1, 2016, 00:00

  • The Value Of Patient Reported Outcomes In German Amnog Dossiers

    Nov 1, 2016, 00:00

  • Pricing and Market Access of Orphan Drugs in China- Analysis of National and Provincial Policy and the Associated Impact on Coverage

    Nov 1, 2016, 00:00

  • The Increasing Importance of A Continence Nurse Specialist To Improve Outcomes And Save Costs of Urinary Incontinence Care- An Analysis of Future Policy Scenarios

    Nov 1, 2016, 00:00

  • Evaluation of the Direct Costs of Health Care During the First Year of Life of Babies Born with Microcephaly in the SUS

    Nov 1, 2016, 00:00

  • Widening Engagement with HTA Though open online Learning

    Nov 1, 2016, 00:00

  • Market Access In The Context Of Economic Crisis- Insights From Several European Countries

    Nov 1, 2016, 00:00

  • Impact of National Orphan Drug Policy and Reimbursement Mechanisms Over the Implementation of Managed Entry Agreements in Select Asia-Pacific Countries

    Nov 1, 2016, 00:00

  • A Secure Smartphone Application For Clinical Research On Wound Healing- Nurstrial

    Nov 1, 2016, 00:00

  • A Review on the Current Status of Health Economic Modeling in Personalized Medicine

    Nov 1, 2016, 00:00

  • Adverse Events in Relaxing Virtual Environments

    Nov 1, 2016, 00:00

  • Evaluating The Cost-Benefit of A Cognitive Assessment and Training Program Across A Smart City Population in The UK

    Nov 1, 2016, 00:00

  • Study on Age-Related Drug Use Pattern and Assessment of Medication Adherence in Patients with Chronic Respiratory Diseases

    Nov 1, 2016, 00:00

  • The Effect of Necitumumab in Combination with Gemcitabine-Cisplatin on Health-Related Quality of Life (HRQOL) and Tolerability- Squire Trial Patients with Epidermal Growth Factor Receptor (EGFR)-Expressing Squamous NSCLC Tumours

    Nov 1, 2016, 00:00

  • A Cost-effectiveness Analysis of Pharmacokinetic (Pk) Driven Prophylaxis VS. Standard Prophylaxis In Haemophilia A

    Nov 1, 2016, 00:00

  • Cost of Treatment of Actinic Keratosis on the Face/Scalp in Sweden

    Nov 1, 2016, 00:00

  • Correctly Capturing Uncertainty in Treatment Effects in Simulation Modeling

    Nov 1, 2016, 00:00

  • Perception Survey on Health Technology Assessment in Turkey- Does Practice Meet with Regulations

    Nov 1, 2016, 00:00

  • Treatment Patterns, Biomarker Testing (BMX) Practices and Healthcare Resource Use (HCRU) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) in Taiwan

    Nov 1, 2016, 00:00

  • Multi-Criteria Decision Analysis (MCDA)- Common Tools for Different Needs Supporting Healthcare Decision Making in Spain

    Nov 1, 2016, 00:00

  • The Evolution Of Patient Access Schemes

    Nov 1, 2016, 00:00

  • Disease Modifying Treatment (Dmt) is Associated with Lower Hazard for Death Among Multiple Sclerosis (Ms) Patients- Survival Analysis Based on 30 Years Incident Ms Cohort

    Nov 1, 2016, 00:00

  • Institute for Clinical and Economic Review (ICER) VS. Health Technology Assessment (HTA) Agencies- The Case of Multiple Myeloma and PCSK9S

    Nov 1, 2016, 00:00

  • Proqolid Database- Evolution Of Content, Structure, And Functionalities (2012-2016) - Integration In Eprovide, A New Online Platform Dedicated To Clinical Outcome Assessment (Coa) Research

    Nov 1, 2016, 00:00

  • Systematic Review Of Studies Estimating The Cost-Effectiveness Of Hiv Pre-Exposure Prophylaxis (Prep) In Men Who Have Sex With Men (Msm)

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life in Patients with Rheumatoid Arthritis At Uttaradit Hospital, Thailand

    Nov 1, 2016, 00:00

  • COPD Drugs In Europe - A Comparison of Market Access Decisions In France, Germany, Sweden and UK with The Prismaccess Database

    Nov 1, 2016, 00:00

  • Direct Costs Of Epilepsy In Turkey- A Panel Approach

    Nov 1, 2016, 00:00

  • Budget Impact of Secukinumab For Ankylosing Spondylitis In The UK

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Obinutuzumab And Ibrutinib In Patients With Chronic Lymphocytic Leukemia In Russia

    Nov 1, 2016, 00:00

  • Don't Put Off Until Tomorrow What You Can Do Today- Cost-Effectiveness of Trastuzumab Plus Paclitaxel Combination Therapy and Sequential use of Paclitaxel and Trastuzumab in the Treatment of Metastatic Breast Cancer in Singapore

    Nov 1, 2016, 00:00

  • Using Subpopulation Treatment Effect Pattern Plot to Identify More Efficient Resource Allocation Policies

    Nov 1, 2016, 00:00

  • Rapid Health Technology Assessment – Valveless Trocar System for Advanced Laparoscopic / Robotic Surgery

    Nov 1, 2016, 00:00

  • Health Care Utilization and Economic Burden of Pancreatic Cancer in The Us Medicare Population

    Nov 1, 2016, 00:00

  • Price And Utilization Of New Drugs Under A Single Public Payer System- Evidence From Taiwan

    Nov 1, 2016, 00:00

  • In-Licensing as a Business Strategy for Pharmaceutical Companies- A Framework for the Nigerian Industry

    Nov 1, 2016, 00:00

  • Pivotal Studies of Oncology Drugs Approved in Europe, Which Evidence Based-Medicine?

    Nov 1, 2016, 00:00

  • Economic Burden of Stroke- A Systematic Review on Post-Stroke Care

    Nov 1, 2016, 00:00

  • Cost-Effectivness Analysis of Axitinib In The Treatment of Metastatic Renal Cell Carcinoma – Clinical Data Vs RWE

    Nov 1, 2016, 00:00

  • The Evaluation Health Education to Elevate Correct Medication Knowledge and Ability in Community

    Nov 1, 2016, 00:00

  • To Evaluate the Outcomes of Concomitant Chemoradiotherapy Followed by Extended Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma - A Retrospective Study

    Nov 1, 2016, 00:00

  • The Patient Journey After A Diagnosis of Early/Locally Advanced Breast CA In Greece And Choice of Provider

    Nov 1, 2016, 00:00

  • Bevacizumab in The Treatment of Kras Wild Type Metastatic Colorectal Cancer- An Economic Analysis Based on The Calgb 80405 Trial

    Nov 1, 2016, 00:00

  • Zinforo (Ceftaroline Fosamil) Versus other Empiric Antibiotics for Moderate-to-Severe Community Acquired Pneumonia (CAP) In Adults- a Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Analysis of Pegylated Liposomal Doxorubicin Versus Doxorubicin In Patients with Metastatic Breast Cancer at High Risk of Cardiac Events

    Nov 1, 2016, 00:00

  • Mapping Transactions from Pharmaceutical Companies to Healthcare Organisations in the EU5

    Nov 1, 2016, 00:00

  • Ethical and Technological Evaluation of Security of Connected Objects and Health Applications- How to Move Towards Certification

    Nov 1, 2016, 00:00

  • The Accuracy of Patient Self Report in Measuring Continuity of Care in Australia

    Nov 1, 2016, 00:00

  • Evaluation of the Number Needed to Vaccinate (NNV) with Gardasil9 in order to Avert 1 Case of Human Papillomavirus (HPV)-Related Anogenital Disease in France

    Nov 1, 2016, 00:00

  • Cost Comparison Of Medical And Surgical Treatments For Medically Intractable Epilepsy

    Nov 1, 2016, 00:00

  • A Case Study on the Development, Implementation and Outcome of Critical Disease Insurance in Shen Zhen, China

    Nov 1, 2016, 00:00

  • Spatial Distribution of the Total Number of Medical Devices in Turkey- A Classification Analysis

    Nov 1, 2016, 00:00

  • Thresholds for Clinical Importance in EORTC-QLQ-C30- Application in A Sample of Colorectal Cancer Patients

    Nov 1, 2016, 00:00

  • Influence of Medical–Economic Analysis on the Categorization of Special Medical Equipment

    Nov 1, 2016, 00:00

  • Review of the Recommendations Made by the National Institute for Health and Care Excellence (NICE) and the Scottish Medicial Consortium (SMC) Relating to Treatments for Rare Diseases

    Nov 1, 2016, 00:00

  • Is there Evidence of a Difference Between Willingness to Pay and Willingness to Accept Thresholds? A Review of Nice Technology Appraisals

    Nov 1, 2016, 00:00

  • Market Access Challenges of Drugs for Chronic Hepatitis C- A Thematic Analysis of Health Technology Assessments

    Nov 1, 2016, 00:00

  • Management of Patients with Statin Intoleran Results from a Survey of Clinicians in Six European Countries

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Tocilizumab Subcutaneouscombotherapy First Line For The Management of Rheumatoid Arthritis In Greece

    Nov 1, 2016, 00:00

  • The Adoption of Roles by Primary Care Providers During Implementation of The New Chronic Disease Guidelines in Urban Mongolia- A Qualitative Study

    Nov 1, 2016, 00:00

  • The Impact of Haemophilia Complications on Health-Related Quality of Life for Adults with Severe Haemophilia

    Nov 1, 2016, 00:00

  • Assessment Of Prices Of Essential Medicines For Chronic Diseases Prevalent In The Asia Pacific Region

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Introducing Pharmacist-Managed Warfarin Service In The Republic of Serbia

    Nov 1, 2016, 00:00

  • Are Allocation Preferences In Health Care Consistent With A Particular Definition Of Severity? Results From A Random-Sample Survey Of Norwegians

    Nov 1, 2016, 00:00

  • The Trends of Emergency Care Admissions Focusing on The Population Over 65 Years of Age

    Nov 1, 2016, 00:00

  • Automatic Extraction and Classification of Patients’ Smoking Status from Free Text Using Natural Language Processing

    Nov 1, 2016, 00:00

  • Clinical Outcome and Health Care Costs of Blood Stream Infections with Resistant Klebsiella Pneumoniae in Pediatric Patients

    Nov 1, 2016, 00:00

  • Assure-Csu- Resource Use and Economic Burden in Patients with Refractory Chronic Spontaneous/Idiopathic Urticaria in Italy

    Nov 1, 2016, 00:00

  • Adaptive Prediction of Symptoms Return Upon Discontinuation of Omalizumab Treatment in Chronic Spontaneous Urticaria Patients

    Nov 1, 2016, 00:00

  • Market Regulation May Influence Drug Price Trajectories - A Comparison of Anti Tumor Necrosis Factor Drug Prices In Israel And The USA

    Nov 1, 2016, 00:00

  • Comparison of Economic Evaluation Guidelines Between Japan and other Countries

    Nov 1, 2016, 00:00

  • Health Resource Use and Cost Under Pay on Fee and Case-Based Payment in Hospitalized Patients with Chronic Obstructive Pulmonary Disease in China

    Nov 1, 2016, 00:00

  • The Prevalence Of Sexual Dysfunctions Among Hungarian Men

    Nov 1, 2016, 00:00

  • The use of Alhijama as Complimentary Treatment in Hypertension

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Levofloxacin Inhalation Solution Vs. Aztreonam Inhalation Solution And Tobramycin Dry Powder For Inhalation In Cystic Fibrosis Patients In Sweden

    Nov 1, 2016, 00:00

  • Good Cop, Bad Cop; G-BA and Iqwig in Clinical Outcome Evaluations

    Nov 1, 2016, 00:00

  • Switching Patterns from Warfarin to Non-Vitamin K Oral Anticoagulants In Ireland

    Nov 1, 2016, 00:00

  • Literature Review of Studies Evaluating Cost Effectiveness of Prostaglandins and ß-Blockers in Primary Open Angle Glaucoma Patients

    Nov 1, 2016, 00:00

  • Non-Parametric Approach to Estimating Expected Value of Perfect Information- The Usefulness of this Approach to a National HTA Agency

    Nov 1, 2016, 00:00

  • Perioperative Therapies Reducing Homologous Transfusions During Cardiovascular Surgery- A Network Meta-Analysis of Randomized Controlled Trials

    Nov 1, 2016, 00:00

  • The Medication Adherence in Schizophrenia Management by Using Second Generation Antipsychotics in Taiwan- A Population Study Based on Nhrid

    Nov 1, 2016, 00:00

  • When Cost Saving Technologies are Not Adopted Despite Evidence and Payer Recommendations – Intraoperative Fluid Management (IOFM) in the UK

    Nov 1, 2016, 00:00

  • Bilirubin and Neurodegenerative Disease Prevention

    Nov 1, 2016, 00:00

  • Cost of Sorafenib for Russian Government Drug Provision Program

    Nov 1, 2016, 00:00

  • Health Insurance-Related Aspects Of Home-Based Parenteral Nutrition In Hungary

    Nov 1, 2016, 00:00

  • Assessment Of Knowledge And Practice Regarding Foot Care Of Diabetes Mellitus Patient In Tertiary Care Hospitals, Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Rituximab in the Treatment of Diffuse Large B-Cell Non-Hodgkin's Lyphoma Patients (Dlbcl) in China

    Nov 1, 2016, 00:00

  • A Patient Level Simulation Model

    Nov 1, 2016, 00:00

  • Prevalence and Management of Anemia in Patients of Chronic Kidney Disease at a Tertiary Care Public Teaching Hospital- Evidence from a Cross Sectional Study

    Nov 1, 2016, 00:00

  • A Quantitative Analysis of Health Technology Assessment (HTA) Agencies for Attributes Driving Transparency of the Organization- Comparison of Six Asia-Pacific HTA Agencies

    Nov 1, 2016, 00:00

  • Matching Adjusted Indirect Comparison (MAIC) Analysis For Ponatinib Vs Bosutinib In Third-Line Chronic Phase Chronic Myeloid Leukemia (CP-CML)

    Nov 1, 2016, 00:00

  • Inflammatory Back Pain- Impact on Working Hours, and Quality of Life at 12 Months

    Nov 1, 2016, 00:00

  • Zinforo (Ceftaroline Fosamil) Versus other Empiric Initial IV Antibiotics for Complicated Skin and Soft Tissue Infections (CSSTI)- A Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Treatment Cost Estimation of Chronic Gastritis Caused by Helicobacter Pylori

    Nov 1, 2016, 00:00

  • Social Return on Investment in Psoriasis

    Nov 1, 2016, 00:00

  • Drivers in HTA Decision-Making for Cholesterol Lowering PCSK9 Inhibitors

    Nov 1, 2016, 00:00

  • Cardiovascular Diseases- Pharmacotherapy Utilization In Western Europe and CEE

    Nov 1, 2016, 00:00

  • Economic Evaluation of Everolimus as Second-Line Treatment of Metastatic Renal Cell Carcinoma in Greece

    Nov 1, 2016, 00:00

  • HTA On Role of Chitosan In Hemostasis

    Nov 1, 2016, 00:00

  • A Cross-National Comparison Of The Effect Of Age And Gender On Health-Related Quality Of Life (Hrql)

    Nov 1, 2016, 00:00

  • Comprehensive Evaluation of Health Care Workers Perceptions and Attitude on Pharmacists Involvement in Ward Round in Three Tertiary Hospitals in South-East Nigeria

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Insulin Degludec/Insulin Aspart (IDEGASP) Compared with Biphasic Insulin Aspart (BIASP 30) in Patients with Type 2 Diabetes Mellitus from a Mexican Healthcare Perspective

    Nov 1, 2016, 00:00

  • The Shift From A Compassionate Drug Use To The Common Market–Access Process- An Inflationary No Man’s Land?

    Nov 1, 2016, 00:00

  • Making Sense of Clinical Data Reported in Secondary Conditions- The Epidemiology and Clinical Burden of Hyperglycaemia

    Nov 1, 2016, 00:00

  • Comparing Preferences Of Patients With Rheumatic Diseases, Of Experienced Rheumatologists, Nurses And Pharmacists Toward The Treatment Of Rheumatic Diseases With Biological Agents- Results From The Cara Study

    Nov 1, 2016, 00:00

  • Parametric and Non-Parametric Approaches for Predicting Bacterial Resistance

    Nov 1, 2016, 00:00

  • Antiviral Activity and Embryonic Toxicity of Moxidectin Against Influenza Virus H9

    Nov 1, 2016, 00:00

  • The Economic Impact of Tobacco Smoking In The Latin-American Healthcare Systems- A Study Conducted In Seven Countries And Its Extrapolation At The Regional Level

    Nov 1, 2016, 00:00

  • DPP-4 Inhibitors and Cardiovascular Events in Type 2 Diabetic Patients with Chronic Kidney Disease -- A Nationwide Cohort Study

    Nov 1, 2016, 00:00

  • Drug Use Analysis of Patients with Hypertension and Diabetes in Shanghai, China- Based on Drug Bidding Database of Shanghai Medical Instituions

    Nov 1, 2016, 00:00

  • Real World Anaplastic Lymphoma Kinase (ALK) Rearrangement Testing Patterns, Treatment Sequences and Survival of ALK-Inhibitor Treated Patients

    Nov 1, 2016, 00:00

  • The Cancer Drugs Fund- The Evolving Assessment Process

    Nov 1, 2016, 00:00

  • Important Methodological Considerations and Strategies for Resolution for Multinational Retrospective Chart Review Studies

    Nov 1, 2016, 00:00

  • Increasing the Interpretability of Patient-Reported Outcomes Questionnaire Findings Using A Mixed Methods Design- An Example in A Rare Cardiac Clinical Trial

    Nov 1, 2016, 00:00

  • Is the Integrated Electronic Health Record Cost-Effective for a Cancer Consultation? Results from the E-SI (PREPS-SIPS) Study

    Nov 1, 2016, 00:00

  • Which Medical Device for Urinary Incontinence Provides Patient The Higher Quality of Life?

    Nov 1, 2016, 00:00

  • Effective Use of Short-Term Healthcare By Immigrants In Chile- Linking Evidence To Policy For Universal Coverage

    Nov 1, 2016, 00:00

  • An Indirect Comparison Between Adalimumab, Baricitinib And Tofacitinib For The Treatment of Rheumatoid Arthritis

    Nov 1, 2016, 00:00

  • Reform of Chinese State-Owned Enterprise-Affiliated Hospital

    Nov 1, 2016, 00:00

  • Economic Evaluation of The Portuguese Needle Exchange Programme In Community Pharmacies (NEP-CP)

    Nov 1, 2016, 00:00

  • Tasks Involved In Platelet Production And Transfusion From The U.S. Hospital Perspective- Two Process Frameworks

    Nov 1, 2016, 00:00

  • Management of Children's Acute Diarrhea by Community Pharmacies in Five Towns of Ethiopia- Simulated Client Case

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Pasireotide Long-Acting Compared To Continued Use of A First-Line Somatostatin Antagonist For The Treatment of Acromegaly In Sweden

    Nov 1, 2016, 00:00

  • Health Insurance Treatment Cost of Colorectal Cancer in Hungary

    Nov 1, 2016, 00:00

  • Cost Per Responder of Lixisenatide Versus Rapid-Acting Insulin Intensification Regimens in an Insulin-Exposed Type 2 Diabetes Mellitus (T2DM) Population

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Nivolumab Monotherapy for Metastatic Melanoma Treatment

    Nov 1, 2016, 00:00

  • Retrospective Database Study Describing Patient Characteristics And Resource Use in Swedish Patients Receiving Second Generation Long Acting Injection Antipsychotics

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Rifaximin-Α Administration for the Reduction of the Overt Hepatic Encephalopathy Episodes in Recurrence in France

    Nov 1, 2016, 00:00

  • Cost Patterns in Patients Treated with Spinal Cord Stimulation Following Spine Surgery—A Register Based Study

    Nov 1, 2016, 00:00

  • Real World Data on the Adherance to the National Policy of Integrative and Complementary Practices in the Brazilian Unified Health System - The Acupuncture Case

    Nov 1, 2016, 00:00

  • The Evolution of Risk-Sharing Agreements in the Process of Updating the National List of Health Services in Israel

    Nov 1, 2016, 00:00

  • The Coordination Of Care In Pmaq-Ab- An Analysis Based On The Item Response Theory

    Nov 1, 2016, 00:00

  • 19th Euro - FDS Financial Disclosure Statements

    Nov 1, 2016, 00:00

  • A Cost of Illness Study Evaluating The Burden of Wolfram Syndrome In The United Kingdom

    Nov 1, 2016, 00:00

  • Treatment of Osteochondral Fracture and Medial Patellofemoral Ligament Rupture After Patellar Dislocation

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Sacubitril/Valsartan For The Treatment of Chronic Heart Failure with Reduced Ejection Fraction- The Use of Model Calibration To Improve Generalisability To A UK CHF Population

    Nov 1, 2016, 00:00

  • The Longterm Cost Effectiveness of the “Coaching Patients on Achieving Cardiovascular Health” (Coach) Program in Type 2 Diabetes in Tasmania

    Nov 1, 2016, 00:00

  • Quantification Of Quality Of Life Differences Due To Common Diseases In The Age Group 50+ In The United Kingdom

    Nov 1, 2016, 00:00

  • Investigating Influenza Vaccinations for Risk Groups in Ukraine

    Nov 1, 2016, 00:00

  • The Emerging Roles of Pharmacists in Selected Tertiary Hospitals in Pangasinan and La Union- Focus on Pharmaceutical Care and Pharmacovigilance

    Nov 1, 2016, 00:00

  • Missing the Value of Herd Immunity in Cost-Effectiveness Analysis. A Systematic Review

    Nov 1, 2016, 00:00

  • Effect Of A Multifactorial, Interdisciplinary Intervention On Falls And Fall Rate Of The Older People In The Community

    Nov 1, 2016, 00:00

  • Evaluation of Health Care Costs and Utilization Patterns for Patients with Gout in Taiwan

    Nov 1, 2016, 00:00

  • Comparison of Medical Costs, Health Care Utilization, and Health Outcomes Between the Elderly with and Without Disabilities in Korea

    Nov 1, 2016, 00:00

  • Analysis of Antibiotics’ Use in the Treatment of Tonsillopharyngitis in Children Population of Nis District

    Nov 1, 2016, 00:00

  • High Levels Of Fears Of Patients With Rheumatoid Arthritis Or Axial Spondyloarthritis Are Associated With Gender, Disease Activity, Anxiety And Depression- A Cross-Sectional Study Of 672 Patients

    Nov 1, 2016, 00:00

  • Variations in Stakeholder Preferences between Innovative Pricing Agreement Types Across the EU5

    Nov 1, 2016, 00:00

  • Has Access To Innovative Therapies In Poland Improved Following The 2012 Reimbursement Act?

    Nov 1, 2016, 00:00

  • Number Needed to Treat and Cost Per Clinically Meaningful Outcome of Enzalutamide and Abiraterone Acetate for The Treatment of Metastatic Castration-Resistant Prostate Cancer That Failed Androgen Deprivation Therapy in Brazil

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of National Screening Program for Pulmonary Tuberculosis in Korea

    Nov 1, 2016, 00:00

  • TBO-Filgrastim Patterns of Care by Treatment Site and Setting in The United States, 2014 and 2015

    Nov 1, 2016, 00:00

  • The Good The Bad And The Non-Quantifiable – A Comparison of Rebates on Orphan Drugs Versus Non-Orphan Drugs In Germany

    Nov 1, 2016, 00:00

  • Economic Evaluation of Drug Therapy To Prevent Osteoporotic Fractures In Postmenopausal Women With Osteopenia

    Nov 1, 2016, 00:00

  • Safety Profile of Daclizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Exploring The Potential Value of Improved Care for Secondary Hyperparathyroidism (SHPT) with A Novel Investigational Calcimimetic Therapy

    Nov 1, 2016, 00:00

  • Cost-Utility of Denosumab For The Treatment of Postmenopausal Osteoporosis In Colombia

    Nov 1, 2016, 00:00

  • Assessment of Adhesion Response To 3D Printed Materials For Ophthalmic Device Development

    Nov 1, 2016, 00:00

  • Health Economics Analyses for Medical Devices in Asia- A Literature Review

    Nov 1, 2016, 00:00

  • GLP-1 Receptor Agonist Treatment-Related Features Important to Type 2 Diabetes Mellitus (T2DM) Patients- A Preference Study in Germany

    Nov 1, 2016, 00:00

  • Health Care Applicability of A Patient-Centric Web Portal For Patients' Medication Experience

    Nov 1, 2016, 00:00

  • How much do the insured citizens know about the personal account of china's urban employees' basic medical insurance and what are their needs? Evidence from guizhou, china

    Nov 1, 2016, 00:00

  • Cost Variations of Inpatient, Daycare and Outpatient Hysteroscopy in A Tertiary-Care Hospital in Malaysia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of D-Dimer in The Diagnosis of Venous Thromboembolism in Colombia

    Nov 1, 2016, 00:00

  • The Burden of Selected Cancers in The United States- Health Behaviors and Healthcare Utilization of Survivors

    Nov 1, 2016, 00:00

  • Health State Utility Values (Hsuvs) Measured By The Euroqol 5-Dimensions (Eq-5d) Questionnaire In People Living With Hiv (Plhiv)- A Systematic Literature Review (Slr) Using Rapid Review Methodology

    Nov 1, 2016, 00:00

  • A Cost-Utility Analysis of the Risk Model-Guided Antiemetic Prophylaxis Versus Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer- A Net-Benefit Regression Approach

    Nov 1, 2016, 00:00

  • Burden of Low Vision and Blindness in Chinese Elder Popullation-Data from Field Survey

    Nov 1, 2016, 00:00

  • Global Evaluation of European Submission Template to Inform HTA and Payer Submissions

    Nov 1, 2016, 00:00

  • Decision Uncertainty and Need for Further Research- A Case-Study in Fenestrated Endovascular Aneurysm Repair for Complex Abdominal Aortic Aneurysms

    Nov 1, 2016, 00:00

  • Evaluating The Experiential Quality of Older People's Community Care- A Concept Mapping Approach To Instrument Design

    Nov 1, 2016, 00:00

  • Systematic Review of Eq-5d Based Utility Scores in Leukemias

    Nov 1, 2016, 00:00

  • Invisible Lever for Access to Innovative Therapies in Bulgaria

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Of Two Type-A Botulinum Toxins In The Management Of Blepharospasm And Cervical Dystonia In Spain

    Nov 1, 2016, 00:00

  • A Systematic Review Comparing Studies of Cardiovascular Event Utilities by Geographic Region

    Nov 1, 2016, 00:00

  • Clinical Responses and Improvements in Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol

    Nov 1, 2016, 00:00

  • Use of Real World Data in Identifying Relevant Comparators in Medico Economic Models at EU5 Level- A Case Study on Multiple Myeloma

    Nov 1, 2016, 00:00

  • Measuring Of The Uncertainty In Reimbursement System For Medicinal Products

    Nov 1, 2016, 00:00

  • Dose Increase Beyond Labelled Dose of Biologic Treatments in Moderate to Severe Psoriasis is Associated with Incremental Pharmacy Costs- A Real-World Study in the UK

    Nov 1, 2016, 00:00

  • Course of Therapy, Resource Utilization and Costs for The Treatment of Metastatic Colorectal Cancer in Germany

    Nov 1, 2016, 00:00

  • Central Nervous System, Multiple Sclerosis And Social Security- The Economic Burden On The Social Security System Pensions In Italy

    Nov 1, 2016, 00:00

  • Cost of Illness Study In Patients With Myasthenia Gravis Treated With Plasma Exchange Therapy In Belgium

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilisation Associated with Patients Treated with Either Exenatide Once Weekly or Basal Insulin- A Retrospective UK Database Analysis

    Nov 1, 2016, 00:00

  • Current Issues and Future Research Priorities for Health Economic Modelling of at Risk Population for Alzheimer’s Disease/Dementia

    Nov 1, 2016, 00:00

  • Observational Study on Daily Life Practice in 15039 Patient with Multiple Sclerosis in France

    Nov 1, 2016, 00:00

  • Trend in HBA1C Levels Among Primary Care Diabetes Patients Admitted to a Tertiary Hospital in Singapore in 2013

    Nov 1, 2016, 00:00

  • Stroke Treatment Cost Analysis for Consideration on Health Cost Determination Using INA-CBG'S (Indonesia Case Based Groups) in Indonesia National Health Insurance Programme 2014

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Brivaracetam Versus Other Antiepileptic Drugs Used as Adjunctive Treatment for Focal Seizures in the Uk- A Discrete Event Simulation Model

    Nov 1, 2016, 00:00

  • Self-Medication with Antibiotics in Sana'a City

    Nov 1, 2016, 00:00

  • The Burden of Severe Asthma in France

    Nov 1, 2016, 00:00

  • The Prescribing, Inpatient, Outpatient and Social Care Costs Associated with Atrial Fibrillation in Scotland- A Record Linkage Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Brentuximab Vedotin in Relapsed or Refractory Hodgkin's Lymphoma Following Autologous Stem Cell Transplant in Taiwan

    Nov 1, 2016, 00:00

  • The Effect of Traditional Medicine on Quality of Life in Patients with Atopic Dermatitis- A Review of Recent Clinical Trials

    Nov 1, 2016, 00:00

  • Health Related Quality of Life In The Deaf British Signing Population

    Nov 1, 2016, 00:00

  • Patient Access to High-Cost and High-Value Specialty Products in China- Review of Decisions From Zhejiang, Neimenggu, Shandong and Jiangxi

    Nov 1, 2016, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79 (current)
  • 80
  • »